Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Renasight Clinical Application, Review and Evaluation (RenaCARE) Study

← catalyst calendar

NCT05846113

Sponsored by Natera, Inc. (industry) · NTRA — their whole pipeline →.

Phase
Not applicable
Status
Unknown status
Study type
Interventional
Design
Na · None · Diagnostic
Enrollment
1,720actual
Sites
31
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2021-06-07actualWhen the study began enrolling
Primary completionAug 2025estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionAug 2025estimatedThe whole study's end, after follow-up
First posted2023-05-06actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2023-09-28actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Kidney Diseases

Intervention

  • Diagnostic test: Renasight

Primary outcomes

what the primary-completion date above is the date OF
Test Positive Prevalence: The frequency of positive test results across the entire cohort and within different categories of kidney disorders will be analyzed.
measured Within 3 months of recruitment close
Frequency of positive test results of Renasight compared to frequency of positive test results of phenotypic panels
measured Within 6 months of recruitment close
Number of participants with changed treatment or clinical management and new clinical diagnoses established based on Renasight test results.
measured Within 3 years and 6 months of recruitment close

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NTRA's whole pipeline · Catalyst calendar · Every registered study · What changed